Decreased expression of SLC 39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer

por Xu, Xiao-Ming, Wang, Cheng-Gong, Zhu, Yu-Di, Chen, Wei-Hua, Shao, Si-Liang, Jiang, Fu-Neng, Liao, Qian-De
Publicado 2016

Overexpression of TPX2 is associated with progression and prognosis of prostate cancer

por Zou, Jun, Huang, Rui-Yan, Jiang, Fu-Neng, Chen, De-Xiong, Wang, Cong, Han, Zhao-Dong, Liang, Yu-Xiang, Zhong, Wei-De
Publicado 2018

CRISPR/Cas9 (D10A) nickase-mediated Hb CS gene editing and genetically modified fibroblast identification

por Wu, Wei-Hao, Ma, Xiao-Mei, Huang, Jian-Qing, Lai, Qin, Jiang, Fu-Neng, Zou, Cui-Yun, Chen, Long-Tian, Yu, Lian
Publicado 2022

BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression

por LING, XIAO-HUI, CHEN, ZHI-YUN, LUO, HONG-WEI, LIU, ZE-ZHEN, LIANG, YING-KE, CHEN, GUAN-XING, JIANG, FU-NENG, ZHONG, WEI-DE
Publicado 2016

Association Between Cd Exposure and Risk of Prostate Cancer: A PRISMA-Compliant Systematic Review and Meta-Analysis

por Ju-Kun, Song, Yuan, Dong-Bo, Rao, Hao-Fu, Chen, Tian-Fei, Luan, Bo-Shi, Xu, Xiao-Ming, Jiang, Fu-Neng, Zhong, Wei-De, Zhu, Jian-Guo
Publicado 2016

Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer

por Qin, Guo-qiang, He, Hui-chan, Han, Zhao-dong, Liang, Yu-xiang, Yang, Sheng-bang, Huang, Ya-qiang, Zhou, Liang, Fu, Hao, Li, Jie-xian, Jiang, Fu-neng, Zhong, Wei-de
Publicado 2014

Functional classification of prostate cancer-associated miRNAs through CRISPR/Cas9-mediated gene knockout

por Jiang, Fu-Neng, Liang, Yu-Xiang, Wei, Wang, Zou, Cui-Yun, Chen, Guan-Xing, Wan, Yue-Ping, Liu, Ze-Zhen, Yang, Yang, Han, Zhao-Dong, Zhu, Jian-Guo, Zhong, Wei-De
Publicado 2020

An Integrative Proteomics and Interaction Network-Based Classifier for Prostate Cancer Diagnosis

por Jiang, Fu-neng, He, Hui-chan, Zhang, Yan-qiong, Yang, Deng-Liang, Huang, Jie-Hong, Zhu, Yun-xin, Mo, Ru-jun, Chen, Guo, Yang, Sheng-bang, Chen, Yan-ru, Zhong, Wei-de, Zhou, Wen-Liang
Publicado 2013

Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients

por He, Hui-chan, Han, Zhao-dong, Dai, Qi-shan, Ling, Xiao-hui, Fu, Xin, Lin, Zhuo-yuan, Deng, Ye-han, Qin, Guo-qiang, Cai, Chao, Chen, Jia-hong, Jiang, Fu-neng, Liu, Xingyin, Zhong, Wei-de
Publicado 2013

CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer

por Chen, Guo, Liang, Yu-xiang, Zhu, Jian-guo, Fu, Xin, Chen, Yan-fei, Mo, Ru-jun, Zhou, Liang, Fu, Hao, Bi, Xue-cheng, He, Hui-chan, Yang, Sheng-bang, Wu, Yong-ding, Jiang, Fu-neng, Zhong, Wei-de
Publicado 2014

Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

por Lin, Zhuo-yuan, Chen, Guo, Zhang, Yan-qiong, He, Hui-chan, Liang, Yu-xiang, Ye, Jian-heng, Liang, Ying-ke, Mo, Ru-jun, Lu, Jian-ming, Zhuo, Yang-jia, Zheng, Yu, Jiang, Fu-neng, Han, Zhao-dong, Wu, Shu-lin, Zhong, Wei-de, Wu, Chin-Lee
Publicado 2023

MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

por Lin, Zhuo-yuan, Chen, Guo, Zhang, Yan-qiong, He, Hui-chan, Liang, Yu-xiang, Ye, Jian-heng, Liang, Ying-ke, Mo, Ru-jun, Lu, Jian-ming, Zhuo, Yang-jia, Zheng, Yu, Jiang, Fu-neng, Han, Zhao-dong, Wu, Shu-lin, Zhong, Wei-de, Wu, Chin-Lee
Publicado 2017

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

por Lin, Zhuo-yuan, Chen, Guo, Zhang, Yan-qiong, He, Hui-chan, Liang, Yu-xiang, Ye, Jian-heng, Liang, Ying-ke, Mo, Ru-jun, Lu, Jian-ming, Zhuo, Yang-jia, Zheng, Yu, Jiang, Fu-neng, Han, Zhao-dong, Wu, Shu-lin, Zhong, Wei-de, Wu, Chin-Lee
Publicado 2019